Answer
Yes. NHS England commissions it for selected adults needing elective prevention of immune TTP relapse who are refractory or intolerant to rituximab, subject to published policy criteria.
Sources for this answer
- NHSNHS · NHS medicine guidance
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.